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Primary carnitine deficiency or carnitine transporter deficiency is an inborn error 
of fatty acid transportation caused by a defect in carnitine transport across plasma 
membrane and impairs the entry of long-chain fatty acids into the mitochondrial 
matrix. Leading to a variety of symptoms such as, cardiomyopathy, muscle 
weakness, non ketotic hypoglycemia and hepatic involvement. Acute episodes 
may be induced by metabolic stress such as prolong fasting, infections or 
vomiting.
Pathophysiology: Primary carnitine deficiency is caused by a defect in the 
plasma membrane carnitine transporter, with urinary loss of carnitine causing 
systemic Intracellular carnitine deficiency that impairs the entry of long-chain 
fatty acids into the mitochondrial matrix. Consequently, impairs the production 
of ketone bodies due to defect of beta-oxidation and energy production.
Signs and symptoms: The presentation of patient is varied, from asymptomatic 
to lethal cardiac manifestations. May be present with non ketotic hypoglycemia 
encephalopathy, seizure, apnea, myopathy, liver dysfunction and cardiomyopathy 
Diagnosis: Primary carnitine deficiency must be considered in every child with 
emergency situation such as seizures, apnea, coma, cardiomyopathy, or episode 
of hypoketotic hypoglycemia, encephalopathy and Reye syndrome presentation.
Hyperuricemia and Elevated Ammonia and liver transaminases and serum 
CK levels may be observed in primary carnitine deficiency. On the other 
hand several patients with primary carnitine deficiency have been detected by 
newborn screening programs. 
Enzyme and Carnitine transport assay in cultured fibroblasts and Mutation 
analysis are methods for confirmation of diagnosis.
Also in imaging study chest x Ray reveals cardiac enlargement and in the 
echocardiogram cardiac enlargement and increased thickness of the left 
ventricular wall. ECG reveals left ventricular hypertrophy and peaked T waves 
in primary carnitine deficiency. 
Treatment: In acute attack with hypoketotic hypoglycemic encephalopathy, 
start with 4cc/kg D/W 10% and then infusion of serum D/W 10%.
IV carnitine 100 to 200 mg/kg/day in acute attack and continue with oral 
carnitine.
Management of cardiomyopathy
Oral carnitine therapy in primary carnitine deficiency improves, cardiac 
function, fasting ketogenesis , growth, and cognitive performance.
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